From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television

Acurx Pharmaceuticals (ACXP) appears in this release only as a paid commercial advertiser on New to The Street Show #777, a sponsored Bloomberg Television program airing tonight at 6:30 p.m. ET. The commercial blurb reiterates existing positioning: Acurx is developing ibezapolstat as a potential first new class of antibiotics in nearly 40 years, with the FDA agreeing to consider a future application based on two planned trials, Pathfinder and Aspire.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.